Registry of CLH intentions until outcome
Registry of CLH intentions until outcome
Registry of CLH intentions until outcome
The registry of classification and labelling (CLH) intentions until outcome lists the intentions and proposals received by ECHA for a new or revised harmonised classification and labelling of a substance. The proposals are submitted by Member State competent authorities, manufacturers, importers or downstream users.
Interested parties can follow the progress of a proposal through the CLH process, from the notification of the intention to the adoption of the opinion of the Committee for Risk Assessment (RAC). The advance notice enables interested parties to plan and prepare for commenting later on.
Anyone with relevant information on the identity or hazard properties of a substance is encouraged to provide this information to the dossier submitter during the early stages of the process, or at the latest during the consultation.
Where an opinion has been adopted by RAC, the status is indicated as ‘Opinion Adopted’.
Note: The classification tables for those substances that have been reviewed are listed in the ‘Corrigenda to the RAC opinions’ document.
Nickel bis(sulphamidate)
EC / List no: 237-396-1 CAS no: 13770-89-3CLP Annex VI Index number | 028-018-00-4 |
Further substance information | |
Status | Opinion Adopted |
Date of intention | 07-sty-2016 |
Expected date of submission | 08-lip-2016 |
Submitted for accordance check | 08-sty-2016 |
Final submission date | 09-lis-2016 |
Withdrawal date | |
Legal deadline for opinion adoption | 09-maj-2018 |
Submitter | MIDU |
Submitter's email | REACH@umicore.com |
Harmonised classification at the time of the proposal | Resp. Sens. 1, H334 Skin Sens. 1, H317 Muta. 2, H341 Carc. 1A, H350i Repr. 1B, H360D*** STOT RE 1, H372** Aquatic Acute 1, H400 Aquatic Acute 1, M-factor=1 Aquatic Chronic 1, H410 Aquatic Chronic 1, M-factor=1 |
Specific concentration limits at the time of the proposal | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 STOT RE 2; H373: 0,1% ≤ C < 1% |
Proposed harmonised classification by the dossier submitter | Acute Tox. 4, H302 Acute Tox. 4, H332 Resp. Sens. 1, H334 Muta. 2, H341 Carc. 1A, H350i Repr. 1A, H360D STOT RE 1, H372 Aquatic Acute 1, H400 Aquatic Acute 1, M-factor=1 Aquatic Chronic 1, H410 Aquatic Chronic 1, M-factor=1 |
Proposed specific concentration limits by the dossier submitter | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
Regulatory programme | Chemical registered under REACH |
Remarks | |
Start of consultation | 21-lis-2016 |
Deadline for commenting | 16-sty-2017 |
Hazard classes open for commenting | Acute toxicity |
CLH report | |
Annexes to the CLH report | |
Date of opinion | 22-wrz-2017 |
RAC Opinion | |
Background document | |
RCOM (Comments received) | |
Attachments received during consultation (excluding journal articles) | |
Minority opinion(s) | |
Other annexes | |
ATP number and date | ATP14 - (04/10/2019), 09/07/2021 |
Link to ATP | |
Latest update | 26-lip-2022 |
First published | 28-lut-2018 |